Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Lennart Krysander"'
Autor:
Björn Rettrup, Dirk J. Ruiter, Leif Håkansson, Bertil Gustafsson, Lennart Krysander, Annika Håkansson, Monique R. Bernsen
Publikováno v:
Cancer Immunology Immunotherapy, 51, 9, pp. 499-504
Cancer Immunology Immunotherapy, 51, 499-504
Cancer Immunology Immunotherapy, 51, 499-504
Item does not contain fulltext Immunotherapy and combination treatments such as biochemotherapy have shown promise, with higher response rates and a subset of durable responses; however, as the majority of responses are still of short duration, they
Autor:
Gabriella Cohn-Cedermark, Lars Erik Rutqvist, B A Hemming Johansson, Per-Ebbe Jönsson, Mats Breivald, Ulrik Ringborg, Lennart Krysander, Christian Ingvar, Christer Lindholm, Ronny Andersson
Publikováno v:
Cancer. 89:1495-1501
Large, prospective, randomized trials with long term follow-up are required to obtain an unbiased evaluation of the significance of resection margins in patients with cutaneous melanoma.The Swedish Melanoma Study Group performed a prospective, random
Publikováno v:
Clinical Oral Implants Research. 8:506-511
A new design for bone implants, the bottle brush, was recently presented in a pilot study on marrow cavities in the femur of rabbits. In this study, the concept is further evaluated on a mini bottle brush. The fixture, 5 x 7 mm, with an implant shaft
Autor:
Leif Håkansson, Lennart Krysander, Annika Håkansson, B Sander, Bertil Gustafsson, C Bergenwald
Publikováno v:
Melanoma Research. 7:139-146
To our knowledge modulation of the expression of tumour necrosis factor-alpha (TNF-alpha) in malignant melanoma metastases in vivo has not been reported. The expression of TNF-alpha by malignant melanoma cells was studied immunohistochemically using
Autor:
Ulrik Ringborg, Ronny Andersson, Jan Eldh, Barbro Glaumann, Larsolof Hafström, Sten Jacobsson, Per-Ebbe Jönsson, Hemming Johansson, Lennart Krysander, Bengt Lagerlöf, null Swedish Melanoma Study Group
Publikováno v:
Cancer. 77:1809-1814
BACKGROUND The traditional surgical treatment for primary malignant melanoma has often been a wide excision with a margin of about 5 cm. Since the risk of local recurrences is dependent on tumor thickness, thin tumors ( 0.8 and; cc 2.0 mm. The trial
Autor:
Björn Rettrup, Leif Håkansson, Monique R. Bernsen, Annika Håkansson, Bertil Gustafsson, Dirk J. Ruiter, Lennart Krysander
Publikováno v:
Melanoma Research, 13, 401-7
Melanoma Research, 13, 4, pp. 401-7
BASE-Bielefeld Academic Search Engine
Melanoma Research, 13, 4, pp. 401-7
BASE-Bielefeld Academic Search Engine
Item does not contain fulltext Although immunotherapy and biochemotherapy have shown promise, producing a subset of durable responses, for the majority of patients with metastatic melanoma the prognosis is still poor. Therefore there is a great need
Autor:
Monique R. Bernsen, Lennart Krysander, Bertil Gustafsson, Els M.A. van de Westerlo, Annika Håkansson, Leif Håkansson, Toon F. C. M. Smetsers, Dirk J. Ruiter, Björn Rettrup, Toin H. van Kuppevelt
Publikováno v:
Cancer Immunology Immunotherapy, 52, 780-3
Cancer Immunology Immunotherapy, 52, 12, pp. 780-3
Cancer Immunology Immunotherapy, 52, 12, pp. 780-3
Item does not contain fulltext Heparan sulphate (HS) represents a heterogeneous class of molecules on cell membranes and extracellular matrices. These molecules are involved in a variety of biological processes, including immune responses, through th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e08b37fff8e16ee26db2032af8de713
http://hdl.handle.net/2066/122995
http://hdl.handle.net/2066/122995
On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases
Autor:
Lennart Krysander, Leif Håkansson, Björn Rettrup, Dirk J. Ruiter, Monique R. Bernsen, Bertil Gustafsson, Annika Håkansson
Publikováno v:
British Journal of Cancer, 88, 3, pp. 424-31
British Journal of Cancer
BASE-Bielefeld Academic Search Engine
British Journal of Cancer, 88, 424-31
British Journal of Cancer
BASE-Bielefeld Academic Search Engine
British Journal of Cancer, 88, 424-31
Item does not contain fulltext A large number of studies have indicated that specific immune reactivity plays a crucial role in the control of malignant melanoma. In this context, expression of MHC I, MHC II and B7 molecules by melanoma cells is seen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b2a2a0035432939b4e2b798e7c7bc15
https://hdl.handle.net/2066/185115
https://hdl.handle.net/2066/185115
Publikováno v:
Cancer immunology, immunotherapy : CII. 52(4)
For the majority of patients with metastatic malignant melanoma the prognosis is poor. Immunotherapy and biochemotherapy have shown promise with a subset of durable responses, but there is still a great need for a better understanding of the mechanis
Autor:
Annika Håkansson, B. Hjelmqvist, Björn Rettrup, Bertil Gustafsson, L Håkansson, Lennart Krysander
Publikováno v:
British Journal of Cancer
The therapeutic efficacy of biochemotherapy in metastatic malignant melanoma still carries a low remission rate, but with some durable responses. It would therefore be of considerable importance if patients with a high probability of responding could